OMCL vs QDEL: fair value comparison
Omnicell, Inc. and QuidelOrtho Corporation · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, QDEL currently sits closer to the top of our discount ranking. OMCL carries the stronger quality grade.
| OMCL | QDEL | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $37.65 | $17.71 |
| 12-month range | $29.96–$48.70 | $12.64–$31.25 |
| Sector rank | #52 of 113 Healthcare | #50 of 113 Healthcare |
| Quality grade | D | F |
| Momentum grade | — | B |
| Leverage | Low | Moderate |
| Margin trend | — | Expanding |
| Revenue growth | — | Declining |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | Downtrend | Mixed |
| 52-week position | The lower-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: OMCL fair value analysis · QDEL fair value analysis